December 27, 2017
Digital health in pharma definitely had a milestone moment in the fourth quarter with the FDA approval of Abilify MyCite, a new, sensor-enabled version of Otsuka’s drug for schizophrenia powered by Proteus Digital Health’s ingestible sensor technology. In addition to that, the quarter saw numerous other moves by pharma companies around clinical trials, chronic disease management, mental health,...
December 20, 2017
Correction: A previous version of this article misstated that ACE was the name of the mobile app. ACE is the name of PharMedQuest's customer relationship management platform and not the mobile app.
Healthcare management company PharMedQuest announced last week that it has made a strategic investment in helparound, an Israeli company which makes an app that supports and connects patients with...
December 1, 2017
Editor's note: Since publication, some of this story's quotes have been edited for clarity.
With billions of dollars and countless hours of human effort spent each year validating new drugs, devices, and medical interventions, it’s little surprise that the healthcare industry is turning to technology to streamline the process. From participant recruitment to data collection to adherence, clinical...
November 22, 2017
The UK government will open a Centre for Data Ethics and Innovation to ensure ethical standards are at the forefront of AI and data-driven technology development.
The new advisory body will work with regulators, the industry and the government to pave the way for sensible AI adoption.
In addition, more than £75m will be invested to deliver recommendations from Professor Dame Wendy Hall and Jérôme...
November 17, 2017
Correction: An earlier version of this article was unclear about differences between Abilify MyCite and the Proteus Digital Medicine Platform.
Earlier this week, Proteus Digital Health and Otsuka Pharmaceuticals announced that Abilify MyCite, a new, sensor-enabled version of Otsuka’s drug for schizophrenia, had received FDA approval for mental health conditions including schizophrenia and...
November 16, 2017
Express Scripts members will now have access to Propeller’s FDA-cleared digital platform for respiratory health. Today, the two companies announced a partnership which they claim is the largest respiratory digital health deployment with a pharmacy benefit manager yet.
The Propeller system allows a patients to attach a sensor to their inhaler, which is synced to an app on the users smart phone....
November 14, 2017
The first drug in the US with a digital ingestion tracking system has been approved by the FDA.
The pill, Abilify MyCite, is prescribed for treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and as an add-on treatment for depression in adults.
An ingestible sensor embedded in the pill is able to record that the medication was taken – sending...
November 13, 2017
Humana and Johnson & Johnson have each announced a new challenge competition for digital health students and entrepreneurs. The former seeks novel approaches to easy and understandable EHR management with a focus on Medicare-compatibility, and will award up to $10,000. The latter is offering up to $50,000 for new skin care strategies potentially incorporating tracking devices, adherence...
November 9, 2017
Pfizer and the Friends of Haemophilia Society have launched an app game specifically designed to help boys aged four years and older learn about and manage their hemophilia.
Released in Qatar, “HemoHeroes” tasks players with guiding their ‘hero’ through different everyday scenarios, such as exercising, cooking, and bathing. While each of these are designed to be a fun challenge, they also focus...
November 8, 2017
Tel-Aviv, Israel-based Vaica, a producer of cloud-based medication adherence products, has announced a new in-home device to help patients stick to their treatments. The Capsuled device stores medications, and includes reminders, informational materials, and other features designed to better enable patients’ daily medication routines.
"The Capsuled is a unique patient adherence product targeted...